Sign in to view content

Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

Dante Joseph Pieramici, MD

Video
Published 2017

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2024
Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study
Dennis M. Marcus, MD
Annual Meeting Talks
2021
Does the Diabetic Status Influence the Rate of Cataract Surgery Following Pars Plana Vitrectomy Surgery?
Ahmed Sallam, MD PhD FRCOphth
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more